Hiroshi Manki

458 total citations
11 papers, 380 citations indexed

About

Hiroshi Manki is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Hiroshi Manki has authored 11 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 4 papers in Clinical Psychology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Hiroshi Manki's work include Bipolar Disorder and Treatment (4 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Schizophrenia research and treatment (3 papers). Hiroshi Manki is often cited by papers focused on Bipolar Disorder and Treatment (4 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Schizophrenia research and treatment (3 papers). Hiroshi Manki collaborates with scholars based in Japan, Canada and United Kingdom. Hiroshi Manki's co-authors include Shigenobu Kanba, Gohei Yagi, Taro Muramatsu, Susumu Higuchi, Yutaka Ono, Masahiro Asai, Kimio Yoshimura, Hiroko Mizushima, Sachio Matsushita and Eiji Suzuki and has published in prestigious journals such as Psychological Medicine, Journal of Affective Disorders and Psychopharmacology.

In The Last Decade

Hiroshi Manki

11 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Manki Japan 9 175 119 111 60 54 11 380
Enrico Smeraldi Italy 12 245 1.4× 94 0.8× 66 0.6× 95 1.6× 75 1.4× 12 386
J. Sáiz‐Ruiz Spain 13 271 1.5× 67 0.6× 221 2.0× 43 0.7× 30 0.6× 24 493
Slađana Štrkalj Ivezić Croatia 9 157 0.9× 121 1.0× 123 1.1× 77 1.3× 66 1.2× 29 360
María Aragüés Spain 13 229 1.3× 199 1.7× 157 1.4× 67 1.1× 81 1.5× 20 572
Lilijana Oruč Bosnia and Herzegovina 12 151 0.9× 116 1.0× 132 1.2× 107 1.8× 77 1.4× 25 437
Ferid Fathalli Canada 10 231 1.3× 68 0.6× 49 0.4× 93 1.6× 73 1.4× 11 410
M. Lanczik Germany 14 257 1.5× 165 1.4× 94 0.8× 111 1.9× 107 2.0× 28 547
M. Lang Canada 5 210 1.2× 50 0.4× 88 0.8× 75 1.3× 27 0.5× 7 410
Raya Lapidus Israel 5 144 0.8× 100 0.8× 62 0.6× 45 0.8× 104 1.9× 7 412
Boris Rauchverger Israel 4 232 1.3× 80 0.7× 192 1.7× 24 0.4× 29 0.5× 5 378

Countries citing papers authored by Hiroshi Manki

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Manki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Manki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Manki more than expected).

Fields of papers citing papers by Hiroshi Manki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Manki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Manki. The network helps show where Hiroshi Manki may publish in the future.

Co-authorship network of co-authors of Hiroshi Manki

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Manki. A scholar is included among the top collaborators of Hiroshi Manki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Manki. Hiroshi Manki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Takeuchi, Hiroyoshi, Takefumi Suzuki, Hiroyuki Uchida, et al.. (2011). How long to wait before reducing antipsychotic dosage in stabilized patients with schizophrenia? A retrospective chart review. Journal of Psychiatric Research. 45(8). 1083–1088. 6 indexed citations
2.
Takeuchi, Hiroyoshi, Takefumi Suzuki, Hiroyuki Uchida, et al.. (2008). A Randomized, Open-Label Comparison of 2 Switching Strategies to Aripiprazole Treatment in Patients With Schizophrenia. Journal of Clinical Psychopharmacology. 28(5). 540–543. 29 indexed citations
3.
4.
Natsume, Tohru, et al.. (2002). Rapid analysis of protein interactions: On-chip micropurification of recombinant protein expressed in Esherichia coli. PROTEOMICS. 2(9). 1247–1253. 24 indexed citations
5.
Ono, Yutaka, Kimio Yoshimura, Hiroko Mizushima, et al.. (1999). Environmental and Possible Genetic Contributions to Character Dimensions of Personality. Psychological Reports. 84(2). 689–696. 20 indexed citations
6.
Kanba, Shigenobu, Hiroshi Manki, Futoshi Shintani, et al.. (1998). Aberrant interleukin-2 receptor-mediated blastoformation of peripheral blood lymphocytes in a severe major depressive episode. Psychological Medicine. 28(2). 481–484. 15 indexed citations
7.
Muramatsu, Taro, Sachio Matsushita, Shigenobu Kanba, et al.. (1997). Monoamine oxidase genes polymorphisms and mood disorder. American Journal of Medical Genetics. 74(5). 494–496. 30 indexed citations
8.
Ono, Yutaka, Hiroshi Manki, Kimio Yoshimura, et al.. (1997). Association between dopamine D4 receptor (D4DR) Exon III polymorphism and novelty seeking in Japanese subjects. American Journal of Medical Genetics. 74(5). 501–503. 111 indexed citations
9.
Muramatsu, Taro, Sachio Matsushita, Shigenobu Kanba, et al.. (1997). Monoamine oxidase genes polymorphisms and mood disorder. American Journal of Medical Genetics. 74(5). 494–496. 2 indexed citations
10.
Ono, Yutaka, Hiroshi Manki, Kimio Yoshimura, et al.. (1997). Association between dopamine D4 receptor (D4DR) Exon III polymorphism and novelty seeking in Japanese subjects. American Journal of Medical Genetics. 74(5). 501–503. 15 indexed citations
11.
Manki, Hiroshi, Shigenobu Kanba, Taro Muramatsu, et al.. (1996). Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders. Journal of Affective Disorders. 40(1-2). 7–13. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Enrico Smeraldi Breakdown of academic impact, for papers by J. Sáiz‐Ruiz Breakdown of academic impact, for papers by Slađana Štrkalj Ivezić Breakdown of academic impact, for papers by María Aragüés Breakdown of academic impact, for papers by Lilijana Oruč Breakdown of academic impact, for papers by Ferid Fathalli Breakdown of academic impact, for papers by M. Lanczik Breakdown of academic impact, for papers by M. Lang Breakdown of academic impact, for papers by Raya Lapidus Breakdown of academic impact, for papers by Boris Rauchverger
Rankless by CCL
2026